Amended Statement of Ownership (sc 13g/a)
January 19 2016 - 4:08PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
|
|
SCHEDULE 13G |
|
|
Under the Securities Exchange Act of 1934 |
|
(Amendment No. 1)* |
|
Rosetta Genomics
Ltd. |
(Name of Issuer) |
|
Ordinary
Shares, NIS 0.6 par value |
(Title of Class of Securities) |
|
M82183126 |
(CUSIP Number) |
|
December
31, 2015 |
(Date of event which requires filing of this statement) |
|
|
Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed: |
|
¨ |
Rule 13d-1(b) |
x |
Rule 13d-1(c) |
¨ |
Rule 13d-1(d) |
|
(Page 1 of 6 Pages) |
______________________________
*The remainder of this cover page shall
be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. M82183126 | 13G | Page 2 of 6 Pages |
1 |
NAMES OF REPORTING PERSONS
Empery Asset Management, LP |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
|
6 |
SHARED VOTING POWER
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
7 |
SOLE DISPOSITIVE POWER
|
8 |
SHARED VOTING POWER
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.82% |
12 |
TYPE OF REPORTING PERSON
PN |
|
|
|
|
|
CUSIP No. M82183126 | 13G | Page 3 of 6 Pages |
1 |
NAMES OF REPORTING PERSONS
Ryan M. Lane |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
|
6 |
SHARED VOTING POWER
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
7 |
SOLE DISPOSITIVE POWER
|
8 |
SHARED DISPOSITIVE POWER
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.82% |
12 |
TYPE OF REPORTING PERSON
IN |
|
|
|
|
|
CUSIP No. M82183126 | 13G | Page 4 of 6 Pages |
1 |
NAMES OF REPORTING PERSONS
Martin D. Hoe |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
|
6 |
SHARED VOTING POWER
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
7 |
SOLE DISPOSITIVE POWER
|
8 |
SHARED DISPOSITIVE POWER
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
386,136 Ordinary Shares.
515,625 Ordinary Shares issuable upon exercise of Warrants |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.82% |
12 |
TYPE OF REPORTING PERSON
IN |
|
|
|
|
|
CUSIP No. M82183126 | 13G | Page 5 of 6 Pages |
This Amendment No. 1 (this "Amendment") amends
the statement on Schedule 13G filed on November 23, 2015 (the "Original Schedule 13G", the Original Schedule 13G,
as amended, the "Schedule 13G"), with respect to Ordinary Shares, NIS 0.6 par value (the "Ordinary Shares"),
of Rosetta Genomics, Ltd. (the "Company"). Capitalized terms used herein and not otherwise defined in this Amendment
have the meanings set forth in the Schedule 13G. This Amendment amends and restates Items 4 and 5 in their entirety as set forth
below.
Item 4. |
OWNERSHIP. |
|
|
|
The information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person is based on 18,177,361 Ordinary Shares issued and outstanding as of November 2, 2015, as represented on the Form 6-K filed with the Securities and Exchange Commission on December 3, 2015, and the exercise of the reported warrants (the "Reported Warrants"). |
|
|
|
The Investment Manager, which serves as the investment manager to the Empery Funds, may be deemed to be the beneficial owner of all Ordinary Shares held by, and underlying the Reported Warrants held by, the Empery Funds. Each of the Reporting Individuals, as Managing Members of the General Partner of the Investment Manager with the power to exercise investment discretion, may be deemed to be the beneficial owner of all Ordinary Shares held by, and underlying the Reported Warrants held by, the Empery Funds. The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of Ordinary Shares owned by another Reporting Person. Each of the Empery Funds and the Reporting Individuals hereby disclaims any beneficial ownership of any such Ordinary Shares. |
Item 5. |
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. |
|
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [X] |
CUSIP No. M82183126 | 13G | Page 6 of 6 Pages |
SIGNATURES
After reasonable inquiry and to the best
of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
DATED: January 19, 2016
|
|
|
EMPERY ASSET MANAGEMENT, LP |
|
By: EMPERY AM GP, LLC, its General Partner |
|
|
|
By: |
/s/ Ryan M. Lane |
|
|
Name: Ryan M. Lane |
|
Title: Managing Member |
|
|
|
/s/ Ryan M. Lane |
|
|
Ryan M. Lane |
|
|
|
/s/ Martin D. Hoe |
|
|
Martin D. Hoe |
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Sep 2023 to Sep 2024